Katherine Bach Kalin - 13 Aug 2022 Form 3 Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
Director
Signature
/s/ Katherine Bach Kalin
Issuer symbol
SLS
Transactions as of
13 Aug 2022
Net transactions value
$0
Form type
3
Filing time
16 Aug 2022, 16:07:18 UTC
Previous filing
15 Jun 2021
Next filing
03 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLS Common Stock 0 13 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney